N/A N=308 Randomized Single-blind Supportive Care

Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a New Packaging Configuration

Comfort

Bottom Line

View on ClinicalTrials.gov: NCT00659815 ↗

Enrolled (actual)

308

Serious AEs

0.0%

Results posted

Nov 2010

Primary outcome: Primary: Comfort — 90.2; 92.7; 84.5; 87.2 Units on a Scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution Packaged in the Currently Marketed Resin Bottle. (Device); Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution Packaged in a Clear Resin Bottle. (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Bausch & Lomb Incorporated
Primary completion: May 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY Comfort	90.2; 92.7; 84.5; 87.2; 90.3; 93.2	—
PRIMARY Slit Lamp Findings	1; 0; 311; 304	—
PRIMARY Lens Deposits	292; 281; 18; 19	—

Summary

The objective of the study is to evaluate the product performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a new packaging configuration

Eligibility Criteria

Inclusion Criteria

Subject is a habitual wearer of planned replacement soft contact lenses
VA correctable to 0.3 LogMar or better (driving vision)
Clear central cornea
Subject uses a lens care system on a regular basis

Exclusion Criteria

Systemic disease affecting ocular health
Using systemic or topical medications
Wear monovision, multifocal or toric contact lenses
Any grade 2 or greater slit lamp findings

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00659815). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.